Kathy J Warden - Net Worth and Insider Trading

Kathy J Warden Net Worth

The estimated net worth of Kathy J Warden is at least $57 Million dollars as of 2023-09-23. Kathy J Warden is the Chair, CEO and President of Northrop Grumman Corp and owns about 134,583 shares of Northrop Grumman Corp (NOC) stock worth over $57 Million. Details can be seen in Kathy J Warden's Latest Holdings Summary section.

Transaction Summary of Kathy J Warden


Kathy J Warden Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kathy J Warden owns 3 companies in total, including Merck & Co Inc (MRK) , Northrop Grumman Corp (NOC) , and Merck & Co Inc (MRKPRB.PFD) .

Click here to see the complete history of Kathy J Warden’s form 4 insider trades.

Insider Ownership Summary of Kathy J Warden

Ticker Comapny Transaction Date Type of Owner
MRK Merck & Co Inc 2020-03-16 director
NOC Northrop Grumman Corp 2013-01-01 Corp VP & Pres Info Syst
MRKPRB.PFD Merck & Co Inc 2020-03-16 director

Kathy J Warden Latest Holdings Summary

Kathy J Warden currently owns a total of 1 stock. Kathy J Warden owns 134,583 shares of Northrop Grumman Corp (NOC) as of August 4, 2022, with a value of $57 Million.

Latest Holdings of Kathy J Warden

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NOC Northrop Grumman Corp 2022-08-04 134,583 424.90 57,184,317

Holding Weightings of Kathy J Warden

Kathy J Warden Form 4 Trading Tracker

According to the SEC Form 4 filings, Kathy J Warden has made a total of 2 transactions in Northrop Grumman Corp (NOC) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Northrop Grumman Corp is the sale of 10,000 shares on August 4, 2022, which brought Kathy J Warden around $5 Million.

Insider Trading History of Kathy J Warden

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kathy J Warden Trading Performance

GuruFocus tracks the stock performance after each of Kathy J Warden's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kathy J Warden is 5.67%. GuruFocus also compares Kathy J Warden's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kathy J Warden within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kathy J Warden's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kathy J Warden

Average Relative Return


Average relative return per transaction

Outperforming Transactions


1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 1.61 5.67 18.92 5.51 11.04 2.25
Relative Return to S&P 500(%) 0.52 -2.88 14.22 -4.35 2.92 -8.59

Kathy J Warden Ownership Network

Ownership Network List of Kathy J Warden

No Data

Ownership Network Relation of Kathy J Warden

Kathy J Warden Owned Company Details

What does Merck & Co Inc do?

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Who are the key executives at Merck & Co Inc?

Kathy J Warden is the director of Merck & Co Inc. Other key executives at Merck & Co Inc include President & Human Health Int?l Joseph Romanelli , Chief Marketing Officer Chirfi Guindo , and SVP & U.S. Market Johannes Jacobus Oosthuizen .

Merck & Co Inc (MRK) Insider Trades Summary

Over the past 18 months, Kathy J Warden made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 133,401 shares made by Steven Mizell , a net sale of 2,172,853 shares made by Kenneth C Frazier , and a net sale of 4,715 shares made by Joseph Romanelli .

In summary, during the past 3 months, insiders sold 8,839 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 8,839 shares. During the past 18 months, 3,613,019 shares of Merck & Co Inc (MRK) were sold and 409 shares were bought by its insiders, resulting in a net sale of 3,612,610 shares.

Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.


Merck & Co Inc Insider Transactions

No Available Data

Kathy J Warden Mailing Address

Above is the net worth, insider trading, and ownership report for Kathy J Warden. You might contact Kathy J Warden via mailing address: 2980 Fairview Park Drive, Falls Church Va 22042.

Discussions on Kathy J Warden

No discussions yet.